We are live on ! Find out more
SC

Sageview Capital Portfolio holdings

AUM $177M
1-Year Est. Return 36.56%
This Fund
S&P 500
This Quarter Est. Return
+4.19%
1 Year Est. Return
+36.56%
3 Year Est. Return
+334.93%
5 Year Est. Return
+185.88%
10 Year Est. Return
AUM
$311M
AUM Growth
-$5.52M
Cap. Flow
-$16.6M
Cap. Flow %
-5.33%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$11.9M
2
SCOR icon
Comscore
SCOR
+$4.7M

Sector Composition

Rank Sector Weight
1 Financials 83.69%
2 Energy 14.1%
3 Miscellaneous 2.01%
4 Communication Services 0.2%
5 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVER
1
DELISTED
Everbank Financial Corp
EVER
$260M 83.69%
12,912,230
REN
2
DELISTED
Resolute Energy Corporaton
REN
$43.9M 14.1%
1,015,202
ENVI
3
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
$6.26M 2.01%
2,608,725
CNVS icon
4
Cineverse
CNVS
$57.3M
$620K 0.2%
1,244
SCOR icon
5
Comscore
SCOR
$78.4M
-7,165
Closed -$4.7M
PTX
6
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
-222,334
Closed -$11.9M

Similar funds

Sageview Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Sageview Capital held 6 positions worth $311M, down 1.7% from $317M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Sageview Capital withdrew a net $16.6M in Q2 2014, closing 2 positions. Its most notable exit was Pernix Therapeutics Holdings, Inc., an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 84% of assets, up from 80% a quarter earlier, followed by Energy and Miscellaneous.

  • Sageview Capital fully exited Pernix Therapeutics Holdings, Inc. in Q2 2014, selling an estimated $11.9M.
  • Sageview Capital's ten largest holdings make up 100% of its $311M portfolio in Q2 2014.
  • Sageview Capital opened 0 new positions and closed 2 in Q2 2014.
  • Sageview Capital's portfolio value fell 1.7% quarter-over-quarter to $311M.

Based on Sageview Capital's 13F filing for Q2 2014, filed 14 Aug 2014.